scholarly article | Q13442814 |
P2093 | author name string | Lorne Zinman | |
Ari Breiner | |||
Pierre R Bourque | |||
P2860 | cites work | Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients | Q34699979 |
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial | Q38776278 | ||
Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters | Q44418044 | ||
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group | Q72759362 | ||
P433 | issue | 12 | |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
edaravone | Q335099 | ||
P304 | page(s) | E319-E320 | |
P577 | publication date | 2020-03-01 | |
P1433 | published in | Canadian Medical Association Journal | Q5030320 |
P1476 | title | Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics | |
P478 | volume | 192 |
Search more.